372 related articles for article (PubMed ID: 27479945)
1. Huntington's disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels.
Horvath S; Langfelder P; Kwak S; Aaronson J; Rosinski J; Vogt TF; Eszes M; Faull RL; Curtis MA; Waldvogel HJ; Choi OW; Tung S; Vinters HV; Coppola G; Yang XW
Aging (Albany NY); 2016 Jul; 8(7):1485-512. PubMed ID: 27479945
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation profiling in human Huntington's disease brain.
De Souza RA; Islam SA; McEwen LM; Mathelier A; Hill A; Mah SM; Wasserman WW; Kobor MS; Leavitt BR
Hum Mol Genet; 2016 May; 25(10):2013-2030. PubMed ID: 26953320
[TBL] [Abstract][Full Text] [Related]
3. Epigenetics of Huntington's Disease.
Bassi S; Tripathi T; Monziani A; Di Leva F; Biagioli M
Adv Exp Med Biol; 2017; 978():277-299. PubMed ID: 28523552
[TBL] [Abstract][Full Text] [Related]
4. Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease.
Henley SM; Wild EJ; Hobbs NZ; Scahill RI; Ridgway GR; Macmanus DG; Barker RA; Fox NC; Tabrizi SJ
J Neurol; 2009 Feb; 256(2):203-12. PubMed ID: 19266143
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation in Huntington's disease: Implications for transgenerational effects.
Thomas EA
Neurosci Lett; 2016 Jun; 625():34-9. PubMed ID: 26522374
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation in Huntington's disease.
Hyeon JW; Kim AH; Yano H
Neurochem Int; 2021 Sep; 148():105074. PubMed ID: 34038804
[TBL] [Abstract][Full Text] [Related]
7. Somatic expansion of the Huntington's disease CAG repeat in the brain is associated with an earlier age of disease onset.
Swami M; Hendricks AE; Gillis T; Massood T; Mysore J; Myers RH; Wheeler VC
Hum Mol Genet; 2009 Aug; 18(16):3039-47. PubMed ID: 19465745
[TBL] [Abstract][Full Text] [Related]
8. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
[TBL] [Abstract][Full Text] [Related]
9. The number of CAG repeats within the normal allele does not influence the age of onset in Huntington's disease.
Klempíř J; Zidovská J; Stochl J; Ing VK; Uhrová T; Roth J
Mov Disord; 2011 Jan; 26(1):125-9. PubMed ID: 21322024
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's disease.
Wang F; Yang Y; Lin X; Wang JQ; Wu YS; Xie W; Wang D; Zhu S; Liao YQ; Sun Q; Yang YG; Luo HR; Guo C; Han C; Tang TS
Hum Mol Genet; 2013 Sep; 22(18):3641-53. PubMed ID: 23669348
[TBL] [Abstract][Full Text] [Related]
11. Age at onset in Huntington's disease and methylation at D4S95.
Reik W; Maher ER; Morrison PJ; Harding AE; Simpson SA
J Med Genet; 1993 Mar; 30(3):185-8. PubMed ID: 8474105
[TBL] [Abstract][Full Text] [Related]
12. N-terminal mutant huntingtin deposition correlates with CAG repeat length and symptom onset, but not neuronal loss in Huntington's disease.
Layburn FE; Tan AYS; Mehrabi NF; Curtis MA; Tippett LJ; Turner CP; Riguet N; Aeschbach L; Lashuel HA; Dragunow M; Faull RLM; Singh-Bains MK
Neurobiol Dis; 2022 Nov; 174():105884. PubMed ID: 36220612
[TBL] [Abstract][Full Text] [Related]
13. Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.
Hansson O; Castilho RF; Korhonen L; Lindholm D; Bates GP; Brundin P
J Neurochem; 2001 Aug; 78(4):694-703. PubMed ID: 11520890
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic alterations mediate iPSC-induced normalization of DNA repair gene expression and TNR stability in Huntington's disease cells.
Mollica PA; Zamponi M; Reid JA; Sharma DK; White AE; Ogle RC; Bruno RD; Sachs PC
J Cell Sci; 2018 Jul; 131(13):. PubMed ID: 29898922
[TBL] [Abstract][Full Text] [Related]
15. Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.
Moss DJH; Pardiñas AF; Langbehn D; Lo K; Leavitt BR; Roos R; Durr A; Mead S; ; ; Holmans P; Jones L; Tabrizi SJ
Lancet Neurol; 2017 Sep; 16(9):701-711. PubMed ID: 28642124
[TBL] [Abstract][Full Text] [Related]
16. Effect of Apolipoprotein E Genotypes on Huntington's Disease Phenotypes in a Han Chinese Population.
Li XY; Zhang YB; Xu M; Cheng HR; Dong Y; Ni W; Li HL; Wu ZY
Neurosci Bull; 2019 Aug; 35(4):756-762. PubMed ID: 30887245
[TBL] [Abstract][Full Text] [Related]
17. Whole-Brain Connectivity in a Large Study of Huntington's Disease Gene Mutation Carriers and Healthy Controls.
Espinoza FA; Turner JA; Vergara VM; Miller RL; Mennigen E; Liu J; Misiura MB; Ciarochi J; Johnson HJ; Long JD; Bockholt HJ; Magnotta VA; Paulsen JS; Calhoun VD
Brain Connect; 2018 Apr; 8(3):166-178. PubMed ID: 29291624
[TBL] [Abstract][Full Text] [Related]
18. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation study of Huntington's disease and motor progression in patients and in animal models.
Lu AT; Narayan P; Grant MJ; Langfelder P; Wang N; Kwak S; Wilkinson H; Chen RZ; Chen J; Simon Bawden C; Rudiger SR; Ciosi M; Chatzi A; Maxwell A; Hore TA; Aaronson J; Rosinski J; Preiss A; Vogt TF; Coppola G; Monckton D; Snell RG; William Yang X; Horvath S
Nat Commun; 2020 Sep; 11(1):4529. PubMed ID: 32913184
[TBL] [Abstract][Full Text] [Related]
20. miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement.
Hoss AG; Labadorf A; Latourelle JC; Kartha VK; Hadzi TC; Gusella JF; MacDonald ME; Chen JF; Akbarian S; Weng Z; Vonsattel JP; Myers RH
BMC Med Genomics; 2015 Mar; 8():10. PubMed ID: 25889241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
